Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?

被引:0
|
作者
Abdallah, Nadine [1 ]
Kim, Seongho [2 ]
Ayash, Lois [2 ]
Klimecki, Scott [3 ]
Ventimiglia, Marie [3 ]
Alavi, Asif [2 ]
Ratanatharathorn, Voravit [2 ]
Uberti, Joseph [2 ]
Deol, Abhinav [2 ]
机构
[1] Wayne State Univ, Detroit Med Ctr, Dept Med, Detroit, MI USA
[2] Wayne State Univ, Karmanos Canc Inst, Dept Oncol, Detroit, MI 48202 USA
[3] Karmanos Canc Inst, Detroit, MI USA
关键词
ALGORITHM;
D O I
10.1038/s41409-019-0744-5
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
引用
收藏
页码:1655 / 1657
页数:3
相关论文
共 50 条
  • [1] Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?
    Nadine Abdallah
    Seongho Kim
    Lois Ayash
    Scott Klimecki
    Marie Ventimiglia
    Asif Alavi
    Voravit Ratanatharathorn
    Joseph Uberti
    Abhinav Deol
    Bone Marrow Transplantation, 2020, 55 : 1655 - 1657
  • [2] Does Use of Biosimilar G-CSF Change Plerixafor Utilization during Stem Cell Mobilization for Autologous Stem Cell Transplant?
    Abdallah, Nadine
    Kim, Seongho
    Alavi, Asif
    Ayash, Lois
    Ratanatharathorn, Voravit
    Uberti, Joseph P.
    Deol, Abhinav
    BLOOD, 2018, 132
  • [3] Does Use of Biosimilar Zarzio Change Plerixafor Utilization During Stem Cell Mobilization For Autologous Stem Cell Transplant?
    Palma Vallellano, Antonio
    Velarde Lopez de Ayala, Pilar
    Zapata Bautista, Rocio
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 332 - 333
  • [4] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
    E Kaul
    G Shah
    C Chaulagain
    R L Comenzo
    Bone Marrow Transplantation, 2014, 49 : 1233 - 1233
  • [5] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
    Kaul, E.
    Shah, G.
    Chaulagain, C.
    Comenzo, R. L.
    BONE MARROW TRANSPLANTATION, 2014, 49 (09) : 1233 - 1233
  • [6] Preliminary experience on autologous stem cell mobilization with biosimilar G-CSF
    Annaloro, C.
    Colombi, M.
    Onida, F.
    Tagliaferri, E.
    Usardi, P.
    Saporiti, G.
    Marconi, M.
    Cortelezzi, A.
    Deliliers, G. Lambertenghi
    BONE MARROW TRANSPLANTATION, 2011, 46 : S345 - S345
  • [7] Autologous haematopoietic stem cell mobilization with plerixafor and G-CSF: impact of overweight and obesity
    Basak, G.
    Wiktor-Jedrzejczak, W.
    Apperley, J. F.
    Douglas, K.
    Gabriel, I.
    Geraldes, C.
    Hubel, K.
    Jaksic, O.
    Koristek, Z.
    Lanza, F.
    Lemoli, R.
    Mikala, G.
    Selleslag, D.
    Worel, N.
    Mohty, M.
    Duarte, R.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S333 - S333
  • [8] Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide
    Shaughnessy, Paul
    Islas-Ohlmayer, Miguel
    Murphy, Julie
    Hougham, Maureen
    MacPherson, Jill
    Winkler, Kurt
    Silva, Matthew
    Steinberg, Michael
    Matous, Jeffrey
    Selvey, Sheryl
    Maris, Michael
    McSweeney, Peter A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) : 729 - 736
  • [9] Haematopoietic stem cell mobilization with plerixafor and G-CSF in patients with multiple myeloma transplanted with autologous stem cells
    Basak, Grzegorz W.
    Jaksic, Ozren
    Koristek, Zdenek
    Mikala, Gabor
    Basic-Kinda, Sandra
    Mayer, Jiri
    Masszi, Tamas
    Giebel, Sebastian
    Labar, Boris
    Wiktor-Jedrzejczak, Wieslaw
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (06) : 488 - 495
  • [10] Use Of Biosimilar G-CSF Compared With Lenograstim In Autologous Haematopoietic Stem Cell Transplant and In Sibling Allogeneic Transplant
    Uddin, Shab
    Russell, Pippa
    Farrell, Maresa
    Davy, Barbara
    Agrawal, Samir G.
    BLOOD, 2013, 122 (21)